What are your Transurban Group shares really worth?

Transurban Group (ASX:TCL) is a quality business but the price you pay still matters.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shareholders in toll road operator Transurban Group (ASX: TCL) have enjoyed stellar returns over the past one, five and ten years.

While the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has recorded a decline of 6.5%, a gain of 15.3% and a rise of 6.8% over those three time periods respectively, Transurban's share price has rallied 18.1%, 118.5% and 75.6% respectively.

With the share price of Transurban currently trading around the $12 mark, some investors are questioning whether the stock has become over-priced.

While the market is generally more right than wrong when it comes to valuation, individual investors undertaking their own valuation of Transurban need to be aware of some of the key aspects to investing in this $24.5 billion giant.

As an article in the Australian Financial Review recently highlighted, Transurban's key asset – a lease over the Melbourne CityLink – is currently scheduled to end in 2035.

The price you pay matters

Many investors utilise the price-to-earnings (PE) ratio for determining whether a stock is fairly valued, undervalued, or overvalued by comparing it on a relative basis to a peer group or market average.

While in some instances this short-hand valuation technique can provide a roughly accurate answer, arguably it works best for large, established companies with consistent earnings that can be assumed to continue into perpetuity.

In contrast, Transurban's business cannot simply be assumed to continue into perpetuity as all of its operations effectively have an end date.

This makes the vital assumption of perpetuity void!

Rather, a much better way to value Transurban is by utilising a discounted cash flow (DCF) approach over an exclusive time period. It's only through this technique that an investor can, with a reasonable degree of accuracy, value the future cashflows of the group.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »